On July 30, FP2020 and AVAC had a webinar on sexual and reproductive health (SRH) integration: One Year After ECHO: Integration in the Time of COVID. This discussion focused on gains made in the year following the ECHO trial results; how COVID-19 has had an impact on HIV and SRH services and efforts to integrate them; and what the future of HIV/SRH integration can and should look like.

Also, follow our One/One/One campaign here and see what the experts are saying about #SRHintegration.

Panelists:

• Dr. Rachel Baggaley, World Health Organization (WHO), Geneva
• Dr. Nyaradzo Mgodi, University of Zimbabwe-University of California, San Francisco (UZ-UCSF), Zimbabwe
• Wame Jallow, International Treatment Preparedness Coalition (ITPC), Botswana
• Dr. Natasha Salifyanji Kaoma, CopperRose, Zambia

Moderated by:

• Beth Schlachter, Executive Director of FP2020
• Mitchell Warren, Executive Director of AVAC

Watch the recording here.

Back by popular demand! As tuberculosis (TB) is the leading global killer of people living with HIV, TB programming must be prioritized and integrated within life-saving bilateral efforts such as PEPFAR. The expected release of the PEPFAR Country Operational Plans (COPs) provides a critical opportunity for advocates to ensure that the latest developments in TB treatment, prevention and diagnostics are implemented within PEPFAR countries.

Join Treatment Action Group, AVAC, the Elizabeth Glaser Pediatric AIDS Foundation, Health GAP, IMPAACT4TB, and RESULTS on Wednesday, January 23, 9-11am ET, for a webinar on how to strategize and engage in PEPFAR COPs planning to address and strengthen our global response to TB through PEPFAR, and introduce tools to galvanize advocacy efforts.

Panel includes:

• Albert Makone, Public Health Consultant and Health Activist
• Lynette Mabote, Health Activist and Consultant
• Martina Casenghi, CaP TB Project Technical Director, Elizabeth Glaser Pediatric AIDS Foundation

Moderator:

• Lotti Rutter, Associate Director, International Policy and Advocacy, Health GAP

This webinar is free and open to the public, register by clicking here.

On February 20, 2019, the OPTIONS Consortium presented a webinar on the PrEP Communications Accelerator—an interactive tool that assists in the development of a demand creation campaign strategy to promote PrEP uptake among target audiences in sub-Saharan Africa. This webinar covered:

• The role of demand creation strategies to drive PrEP uptake
• An introduction to the PrEP Communications Accelerator
• Examples of how the PrEP Communications Accelerator is applied
• Q&A and Discussion

Presenters

• Elmari Briedenhann, Wits Reproductive Health and HIV Institute, OPTIONS Consortium Member
• Briana Ferrigno, McCann Global Health, OPTIONS Consortium Member

You can watch a recording of the webinar here.

On Tuesday, February 26, The Population Council, IRMA and AVAC presented a webinar to learn how user choice and control inform the Council’s MPT product development strategy.

Speakers:

• Tom Zydowsky, PhD; Senior Scientist, Director of Biomedical Research & Pharmaceutical Development, Center for Biomedical Research
• Barbara Friedland, MPH; Associate II, Clinical Project Manager, Center for Biomedical Research

Moderator:

• Jim Pickett, IRMA

Recording: YouTube / Audio / Slides

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study is an open-label, randomized, clinical trial comparing three highly effective, reversible methods of contraception — the progestogen-only injectable depot-medroxyprogesterone acetate (DMPA), a levonorgestrel implant, and the non-hormonal copper intrauterine device — to evaluate whether there is any difference in the risk of acquiring HIV infection among users of these methods.

Results, expected in mid-2019, will help guide the implementation of safe, effective policies and services that will enable women at high risk of HIV to make fully informed choices about contraception and HIV prevention.

The webinar featured:

• Beth Schlachter, Executive Director, FP2020
• Dr. Jared Baeten, Vice Chair, Department of Global Health, University of Washington, ECHO Consortium
• Dr. Nelly Mugo, Research Associate Professor, Global Health, University of Washington, ECHO Management Committee
• Tamar Abrams, Communications Director, FP2020

You can view the webinar recording below.

The HIV Prevention Market Manager project, funded by the Bill & Melinda Gates Foundation, is applying behavioral research and human-centred design to better understand and reach young women in South Africa with effective HIV prevention.

We previously presented the qualitative results from this study. On May 21, we presented the findings from the quantitative research, in which we surveyed almost 2,000 adolescent girls and young women on the factors that influence their decisions and behaviors along their sexual and reproductive health journey. The combined qualitative and quantitative findings also facilitated the identification of three segments or ‘types’ of AGYW, distinct in their attitudes and behaviors, with the aim of informing the design of targeted strategies, tools and interventions.

Recording: YouTube / Audio / Slides

FP2020 and AVAC held a webinar, A Roadmap for Results: Understanding the ECHO Study Results, with the ECHO team following the results announcement. The webinar explained the trial, provided topline results, outlined next steps, and offered key advocacy messages to help all stakeholders understand the findings.

On Thursday, June 27, women and our allies, participated in an interactive discussion about what the post-ECHO trial agenda for contraception and HIV should look like. This critical call aimed to help inform civil society advocates agenda for an upcoming WHO meeting on this subject. The leaders of the Civil Society Working Group on HC-HIV, members of the ECHO Global Community Advisory Group and young women advocates joined for this discussion with WHO and ECHO management team members.

Recordings & Slides: YouTube / Jared Baeten and Tim Mastro’s Slides / James Kiarie’s Slides